Harvard Bioscience (HBIO) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.55% |
| Dec 31, 2025 | -13.79% |
| Sep 30, 2025 | 9.21% |
| Jun 30, 2025 | 3.81% |
| Mar 31, 2025 | -23.16% |
| Dec 31, 2024 | -0.43% |
| Sep 30, 2024 | -25.21% |
| Jun 30, 2024 | -9.15% |
| Mar 31, 2024 | -8.16% |
| Dec 31, 2023 | -11.09% |
| Sep 30, 2023 | -9.31% |
| Jun 30, 2023 | 2.87% |
| Mar 31, 2023 | 14.93% |
| Dec 31, 2022 | -3.17% |
| Sep 30, 2022 | -12.99% |
| Jun 30, 2022 | -12.25% |
| Mar 31, 2022 | -15.62% |
| Dec 31, 2021 | -19.15% |
| Sep 30, 2021 | 2.40% |
| Jun 30, 2021 | 19.70% |
| Mar 31, 2021 | -28.24% |
| Dec 31, 2020 | 14.32% |
| Sep 30, 2020 | 3.30% |
| Jun 30, 2020 | 13.40% |
| Mar 31, 2020 | 46.67% |
| Dec 31, 2019 | 48.32% |
| Sep 30, 2019 | 5.62% |
| Jun 30, 2019 | 28.39% |
| Mar 31, 2019 | 2.10% |
| Dec 31, 2018 | -6.48% |
| Sep 30, 2018 | -17.11% |
| Jun 30, 2018 | -20.46% |
| Mar 31, 2018 | -171.47% |
| Dec 31, 2017 | 22.04% |
| Sep 30, 2017 | 13.93% |
| Jun 30, 2017 | 20.84% |
| Mar 31, 2017 | 38.87% |
| Dec 31, 2016 | 26.13% |
| Sep 30, 2016 | 37.00% |
| Jun 30, 2016 | -7.09% |
| Mar 31, 2016 | 18.86% |
| Dec 31, 2015 | 11.63% |
| Sep 30, 2015 | 32.69% |